insights_auto
Bakit tumaas ang RGEN 2.32%?
Tingnan ang Higit pang Detalyechevron_right
RGEN:NASDAQ
Repligen Corp
$194.09
arrow_upward
+2.32%(+4.41) 1D
$194.09
0.00% (0.00)
bedtimePagkalipas ng oras ng trabaho
Sarado: Set 28, 4:00:00 PM GMT-4 · USD
search
Lahat ng simbolo
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa RGEN...
Buksan
$187.25
Mataas
$198.87
Mababa
$187.11
Mkt. cap
10.95B
Avg. na dami
1.02M
Dami
0.00
P/E ratio
264.56
Mataas nang 52-wk
$198.87
Mababa nang 52-wk
$100.99
EPS
$0.73
Beta
1.05
Mga natitirang share
56.44M
Bilang ng mga empleyado
2K
Buksan
$187.25
Mataas
$198.87
Mababa
$187.11
Mkt. cap
10.95B
Avg. na dami
1.02M
Dami
0.00
P/E ratio
264.56
Mataas nang 52-wk
$198.87
Mababa nang 52-wk
$100.99
EPS
$0.73
Beta
1.05
Mga natitirang share
56.44M
Bilang ng mga empleyado
2K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
TradingView
·
6 oras ang nakalipas
Why Did KOD, RGEN, BIIB Stocks Rise To 52-Week Highs?
Investing.com UK
·
14 oras ang nakalipas
Form 4 Repligen Corporation For: 28 September By Investing.com
Stock Titan
·
14 oras ang nakalipas
After a stock-unit release, Repligen (RGEN) withheld 421 shares from its CFO to cover taxes.
Profile
Repligen Corporation is an American life sciences company that develops and manufactures products used in biological drug manufacturing. The company is headquartered in Waltham, Massachusetts, and is listed on the Nasdaq under the symbol RGEN. Wikipedia
Tungkol sa Repligen Corp
CEOTony J. Hunt
Mga Empleyado2K
Itinatag1981
HeadquartersWaltham, Massachusetts, Estados Unidos
Sektor-
Websiterepligen.com